ALK and anaplastic large cell lymphoma: This remarkable behavior of NPM-ALK overexpression after TKIs suspension warrants further investigation and it could represent another valid therapeutic option in TKIs resistance ALK-amplified ALCL using the DNA damage response pathway as an ally.